P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST‐IN‐HUMAN STUDY OF INA03, AN ANTI‐CD71 ANTIBODY‐DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS

Saved in:
Bibliographic Details
Published in:HemaSphere 2023-08, Vol.7 (S3), p.e45170e9-n/a
Main Authors: Garciaz, Sylvain, Bories, Pierre, Lopez Almeida, Leonor, Boher, Jean‐Marie, Belanger, Coralie, Recher, Christian, Hermine, Olivier, Vey, Norbert, Launay, Pierre
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3422-a10cad9edb1c67f21c9046bbc8dc3cb5f080be3b903c90fc59204f1bdb9f58d03
cites
container_end_page n/a
container_issue S3
container_start_page e45170e9
container_title HemaSphere
container_volume 7
creator Garciaz, Sylvain
Bories, Pierre
Lopez Almeida, Leonor
Boher, Jean‐Marie
Belanger, Coralie
Recher, Christian
Hermine, Olivier
Vey, Norbert
Launay, Pierre
description
doi_str_mv 10.1097/01.HS9.0000969100.45170.e9
format article
fullrecord <record><control><sourceid>wiley_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_877f29cdffd34c1f968a8c97ba21034e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_877f29cdffd34c1f968a8c97ba21034e</doaj_id><sourcerecordid>HEM3BF06622</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3422-a10cad9edb1c67f21c9046bbc8dc3cb5f080be3b903c90fc59204f1bdb9f58d03</originalsourceid><addsrcrecordid>eNqVUstu1DAUjRBIVKX_YLECqZP6kZe7QW7iTAyZJMpDaFZW4jgl1bSpkgLqjk_gV_glvgTPDAK6xAv73nvuOceLY1mvEbQRpP4FRHZSURuaQz2KILQdF_nQ1vSZdYJdH68odtDzf-qX1tmy3Jh9RCn1sH9i_ShcJ7gERclTsREZK7eg5FWT1hXIY8BAkbCKA3QOYlFW9c9v30VmrqTZsAxUdRNt92uGB8k5MCOW1cLgYeSjQ32VR1vTR2WzBmGevW_WrOZmHxSsFjwzLh9FnRjLlBUVj0BemjouWVjn5idvyovyLWBhYzgpbz7wjWDVK-vF0O4Wffb7PbWamNdhskrztQhZulLEwXjVIqjanuq-Q8rzB4wUhY7XdSroFVGdO8AAdpp0FBKDDMqlGDoD6vqODm7QQ3JqiaNuP7U38n4eb9v5UU7tKA-Dab6W7fwwqp2WgW8MqOqHoSeOQgP1gjZQ1O9ajCBxtNF6d9S6_9zd6l7pu4e53T0RfYrcjZ_k9fRFIuhgij1qFC6PCmqelmXWwx8ygnKfBgmRNGmQf9MgD2mQek8Oj-Sv404__gdTJnxDrmLoeRiTX8fOtAk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST‐IN‐HUMAN STUDY OF INA03, AN ANTI‐CD71 ANTIBODY‐DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>PubMed Central</source><creator>Garciaz, Sylvain ; Bories, Pierre ; Lopez Almeida, Leonor ; Boher, Jean‐Marie ; Belanger, Coralie ; Recher, Christian ; Hermine, Olivier ; Vey, Norbert ; Launay, Pierre</creator><creatorcontrib>Garciaz, Sylvain ; Bories, Pierre ; Lopez Almeida, Leonor ; Boher, Jean‐Marie ; Belanger, Coralie ; Recher, Christian ; Hermine, Olivier ; Vey, Norbert ; Launay, Pierre</creatorcontrib><identifier>ISSN: 2572-9241</identifier><identifier>EISSN: 2572-9241</identifier><identifier>DOI: 10.1097/01.HS9.0000969100.45170.e9</identifier><language>eng</language><publisher>Philadelphia, PA: Lippincott Williams &amp; Wilkins</publisher><ispartof>HemaSphere, 2023-08, Vol.7 (S3), p.e45170e9-n/a</ispartof><rights>Copyright © 2023 The Author(s).</rights><rights>Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3422-a10cad9edb1c67f21c9046bbc8dc3cb5f080be3b903c90fc59204f1bdb9f58d03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429269/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429269/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11561,27923,27924,46051,46475,53790,53792</link.rule.ids></links><search><creatorcontrib>Garciaz, Sylvain</creatorcontrib><creatorcontrib>Bories, Pierre</creatorcontrib><creatorcontrib>Lopez Almeida, Leonor</creatorcontrib><creatorcontrib>Boher, Jean‐Marie</creatorcontrib><creatorcontrib>Belanger, Coralie</creatorcontrib><creatorcontrib>Recher, Christian</creatorcontrib><creatorcontrib>Hermine, Olivier</creatorcontrib><creatorcontrib>Vey, Norbert</creatorcontrib><creatorcontrib>Launay, Pierre</creatorcontrib><title>P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST‐IN‐HUMAN STUDY OF INA03, AN ANTI‐CD71 ANTIBODY‐DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS</title><title>HemaSphere</title><issn>2572-9241</issn><issn>2572-9241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>DOA</sourceid><recordid>eNqVUstu1DAUjRBIVKX_YLECqZP6kZe7QW7iTAyZJMpDaFZW4jgl1bSpkgLqjk_gV_glvgTPDAK6xAv73nvuOceLY1mvEbQRpP4FRHZSURuaQz2KILQdF_nQ1vSZdYJdH68odtDzf-qX1tmy3Jh9RCn1sH9i_ShcJ7gERclTsREZK7eg5FWT1hXIY8BAkbCKA3QOYlFW9c9v30VmrqTZsAxUdRNt92uGB8k5MCOW1cLgYeSjQ32VR1vTR2WzBmGevW_WrOZmHxSsFjwzLh9FnRjLlBUVj0BemjouWVjn5idvyovyLWBhYzgpbz7wjWDVK-vF0O4Wffb7PbWamNdhskrztQhZulLEwXjVIqjanuq-Q8rzB4wUhY7XdSroFVGdO8AAdpp0FBKDDMqlGDoD6vqODm7QQ3JqiaNuP7U38n4eb9v5UU7tKA-Dab6W7fwwqp2WgW8MqOqHoSeOQgP1gjZQ1O9ajCBxtNF6d9S6_9zd6l7pu4e53T0RfYrcjZ_k9fRFIuhgij1qFC6PCmqelmXWwx8ygnKfBgmRNGmQf9MgD2mQek8Oj-Sv404__gdTJnxDrmLoeRiTX8fOtAk</recordid><startdate>20230808</startdate><enddate>20230808</enddate><creator>Garciaz, Sylvain</creator><creator>Bories, Pierre</creator><creator>Lopez Almeida, Leonor</creator><creator>Boher, Jean‐Marie</creator><creator>Belanger, Coralie</creator><creator>Recher, Christian</creator><creator>Hermine, Olivier</creator><creator>Vey, Norbert</creator><creator>Launay, Pierre</creator><general>Lippincott Williams &amp; Wilkins</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230808</creationdate><title>P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST‐IN‐HUMAN STUDY OF INA03, AN ANTI‐CD71 ANTIBODY‐DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS</title><author>Garciaz, Sylvain ; Bories, Pierre ; Lopez Almeida, Leonor ; Boher, Jean‐Marie ; Belanger, Coralie ; Recher, Christian ; Hermine, Olivier ; Vey, Norbert ; Launay, Pierre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3422-a10cad9edb1c67f21c9046bbc8dc3cb5f080be3b903c90fc59204f1bdb9f58d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Garciaz, Sylvain</creatorcontrib><creatorcontrib>Bories, Pierre</creatorcontrib><creatorcontrib>Lopez Almeida, Leonor</creatorcontrib><creatorcontrib>Boher, Jean‐Marie</creatorcontrib><creatorcontrib>Belanger, Coralie</creatorcontrib><creatorcontrib>Recher, Christian</creatorcontrib><creatorcontrib>Hermine, Olivier</creatorcontrib><creatorcontrib>Vey, Norbert</creatorcontrib><creatorcontrib>Launay, Pierre</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley Online Library Free Content</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>HemaSphere</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Garciaz, Sylvain</au><au>Bories, Pierre</au><au>Lopez Almeida, Leonor</au><au>Boher, Jean‐Marie</au><au>Belanger, Coralie</au><au>Recher, Christian</au><au>Hermine, Olivier</au><au>Vey, Norbert</au><au>Launay, Pierre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST‐IN‐HUMAN STUDY OF INA03, AN ANTI‐CD71 ANTIBODY‐DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS</atitle><jtitle>HemaSphere</jtitle><date>2023-08-08</date><risdate>2023</risdate><volume>7</volume><issue>S3</issue><spage>e45170e9</spage><epage>n/a</epage><pages>e45170e9-n/a</pages><issn>2572-9241</issn><eissn>2572-9241</eissn><cop>Philadelphia, PA</cop><pub>Lippincott Williams &amp; Wilkins</pub><doi>10.1097/01.HS9.0000969100.45170.e9</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2572-9241
ispartof HemaSphere, 2023-08, Vol.7 (S3), p.e45170e9-n/a
issn 2572-9241
2572-9241
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_877f29cdffd34c1f968a8c97ba21034e
source Open Access: Wiley-Blackwell Open Access Journals; PubMed Central
title P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST‐IN‐HUMAN STUDY OF INA03, AN ANTI‐CD71 ANTIBODY‐DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T12%3A42%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P548:%20PRELIMINARY%20RESULTS%20OF%20A%20PHASE%201,%20FIRST%E2%80%90IN%E2%80%90HUMAN%20STUDY%20OF%20INA03,%20AN%20ANTI%E2%80%90CD71%20ANTIBODY%E2%80%90DRUG%20CONJUGATE%20IN%20PATIENTS%20WITH%20RELAPSED%20OR%20REFRACTORY%20(R/R)%20ACUTE%20LEUKEMIAS&rft.jtitle=HemaSphere&rft.au=Garciaz,%20Sylvain&rft.date=2023-08-08&rft.volume=7&rft.issue=S3&rft.spage=e45170e9&rft.epage=n/a&rft.pages=e45170e9-n/a&rft.issn=2572-9241&rft.eissn=2572-9241&rft_id=info:doi/10.1097/01.HS9.0000969100.45170.e9&rft_dat=%3Cwiley_doaj_%3EHEM3BF06622%3C/wiley_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3422-a10cad9edb1c67f21c9046bbc8dc3cb5f080be3b903c90fc59204f1bdb9f58d03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true